Obstetric Anesthesia Experiences in COVID-19 Positive Patients
Our Anesthesia Experiences in COVID-19 Positive Patients Undergoing Cesarean Section: A Retrospective Single-center Cohort Study
1 other identifier
observational
61
1 country
1
Brief Summary
At the end of 2019, a new coronavirus named COVID-19 (SARS-CoV-2), one of the lower respiratory tract samples was detected in China. The World Health Organization (WHO) declared it a global epidemic on March 11, 2020, due to the emergence of COVID-19 cases in 113 countries other than China, where the first epidemic occurred, and the spread and severity of the virus. Pregnancy increases susceptibility to respiratory complications of viral diseases. This study aimed to retrospectively evaluate the demographic data of COVID-19 patients undergoing cesarean section, our anesthesia practices, complications, and condition of neonates, and to summarize up-to-date information on COVID-19 in obstetric anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2020
CompletedFirst Submitted
Initial submission to the registry
December 29, 2020
CompletedFirst Posted
Study publicly available on registry
December 31, 2020
CompletedDecember 31, 2020
December 1, 2020
10 months
December 29, 2020
December 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
obstetric anesthesia practices
the type of anesthesia was investigated
until 30 minutes after arrival in the operating room
Secondary Outcomes (1)
anesthesia complications
up to 1 hour after anesthesia
Interventions
Patients who underwent cesarean section and had positive PCR nasopharyngeal swabs for COVID-19 were included in the study. Patients who tested negative and were clinically suspicious were excluded from the study. PCR test was not performed on all elective and emergency pregnant women to be taken for cesarean section in our hospital. It was only applied to patients with symptoms or patients who were suspected. All patient demographics and information about anesthesia were analyzed retrospectively from the patient files.
Eligibility Criteria
Patients who underwent cesarean section and had positive PCR nasopharyngeal swabs for COVID-19
You may qualify if:
- Patients who underwent cesarean section
- Patients who had positive PCR nasopharyngeal swabs for COVID-19
You may not qualify if:
- Patients who tested negative and were clinically suspicious
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences Turkey, Bursa Yuksek Ihtisas Training and Research Hospital
Bursa, Yıldırım, 16290, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Derya Karasu
BursaYuksek Ihtisas Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc Prof.
Study Record Dates
First Submitted
December 29, 2020
First Posted
December 31, 2020
Study Start
March 11, 2020
Primary Completion
December 25, 2020
Study Completion
December 25, 2020
Last Updated
December 31, 2020
Record last verified: 2020-12